Italy Raises VAT On Some Medicines

6 January 1997

Last week the Italian government raised value added tax on somemedicines, under a 4,300 billion lire ($2.8 billion) budget-cutting package.

The package, the last leg of 62,500 billion lire ($40.87 billion) total deficit cuts for 1997, raises VAT to 10% from 4% on the A, B and H classes of drugs provided under the state health service, but should have no real impact on final drug prices or on inflation, say government statements.

The state is seeking to raise 598 billion lire through this move, which will also mean an extra burden to the state health fund, which is to absorb some 357 billion lire of the estimated extra income which the VAT rise should provide, while the overall yearly ceiling for drug spending will have to be revised upwards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight